Shares of Aeluma plunged 10.65% to $12.00 in after-hours trading on September 16 after the small-cap semiconductor company reported a fourth-quarter loss more than three times wider than Wall Street expected. The miss forces investors to confront a hard question: is Aeluma spending its way toward a real business, or simply burning cash faster than it can prove its technology works at scale?

  • The Loss Was the Story, Not the Revenue

Revenue was $0.6 million, compared to $1.3 million in Q4 2025, and was primarily from R&D contracts. That roughly matched the $575,000–$587,000 consensus. But the net loss ballooned to $4.0 million, or ($0.22) per share, versus a loss of just $0.9 million, or ($0.05) per share, a year ago — a massive miss against the ($0.07) estimate. Adjusted EBITDA loss was $2.9 million, compared to a loss of just $0.1 million in the same period last year. Investors read this as runaway spending without proportional revenue gains.

  • Hiring and Equipment Are Eating the Budget The escalating losses follow a pattern visible all year. In Q3, EBITDA losses rose "primarily due to higher salaries, stock-based compensation and employee benefits for new key positions to support business expansion and scaling operations."

The company is also procuring additional manufacturing tools for increased wafer production capacity. The bet is that building people and infrastructure now pays off later — but with full-year revenue essentially flat at $4.5 million versus $4.7 million prior-year, while the full-year net loss tripled to $9.2 million , the gap between investment and revenue is widening, not narrowing.

  • A Thick Cash Cushion — Built Through Dilution

Cash rose to $56.0 million from $37.8 million the prior quarter after Aeluma raised $20.1 million by selling 830,484 shares at an average price of $24.87 — roughly double today's price. That gives the company years of runway at current burn rates, but existing shareholders paid for it through dilution.

  • Government Backing Provides a Safety Net — Not Revenue Yet

Aeluma signed a letter of intent for up to $30 million with the CHIPS R&D Office for AI and advanced computing photonics.

However, the award remains subject to further due diligence and government approvals.

Partnerships with Tower Semiconductor and Sumitomo Chemical add credibility, but none of these milestones have yet translated into meaningful product sales. Until they do, Aeluma's story remains one of potential funded by patience — and patient shareholders just got a lot poorer.